hsi stronger start year ep beat vs estim
believ compani fulli de-risk year term ep even
comparison higher end guidanc rang perhap import
view also seem provid flexibl reinvest think
forthcom
would note exclud yoy benefit later north
american organ sale flattish lose yoy market share
core candi mint gum categori core chocol categori
view gotten quit bit competit late ferrero acquisit nestl us
asset greater level innov mar compani also
fulli leverag mars/wrigley busi combin oper standpoint
importantli pull back advertis consum market
yoy though fair result hsi effort around
spend optim shift spend net gross sale
believ realiz addit weight behind
innov rees thin new kit kat flavor mint dark chocol
warrant view fund part greater anticip
ep result approach believ investor welcom
regard price record yoy benefit price na
encourag us given weve continu see neg yoy price scanner data
part disconnect could well like promot spend
associ clear old format item ahead new bag hit
shelv perhap retail yet fulli flow price
shelf either way continu expect price build sequenti year
critic support full year gross margin guidanc though wed note
volum north america like weaken move past
benefit plan elast follow shelf price increas
quarterli annual ep usd
rais usd
return equiti ttm
link barclay live interact chart
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
equal weight ultim believ key
driver stock near-term like
compani appar visibl ep growth
back aggress cost save activ
return relat invest
upsid case base price-to-earnings
multipl upsid ep estim
reflect acceler organ top line trend
consist market share gain core
downsid case base price-to-earnings
multipl downsid ep estim
reflect price action manifest
 lesser forecast gross margin
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
stock
rais ep estim upper end
hsi reiter full year guidanc rang low end
rang would expect see upward street ep revis well increas still
bit less full ep beat expect upsid use
increment invest weve rais target price price-to-earnings ep
premium peer set averag premium
think warrant given averag ep visibl previou price target
base multipl previou ep estim
project predic price
expect full year gross margin expand slightli deliv
bp yoy wherea previous look modest gross margin
expans encourag key element compani
view better de-risk year ep standpoint
critic compon hsi gross margin expans outlook increment price
expect come form list price trade effici packag chang
deliv yoy posit price/mix said
wrote note back march hershey compani bit sur price
even though understood impact price expect build year
bit surpris yet seen price flow though take-away data
specif recent nielsen data suggest total price/mix yoy
twelv week end part disconnect could well
like promot spend associ clear old format item ahead
new bag hit shelv perhap retail yet fulli flow
price shelf either way find notabl report slightli
posit yoy growth price/mix total compani includ yoy north
america continu expect price build sequenti year
import composit profit growth expect much
differ profit growth fulli driven hsi intern
segment lap profit loss year ago period underw aggress
overhead reduct factor repeat contrast would
expect segment profit growth believ onu north
america deliv profit growth reach hsi ep guidanc case
given dont expect reduct year unlik last year gross
margin expans much import profit growth
regard organ growth compani look faster growth yoy vs
hsi key north america segment forecast organ growth yoy
yoy much simpli due yoy benefit
later holiday wed highlight even though price
acceler sequenti yoy realiz volum north america
like weaken move past benefit plan
elast follow shelf price increas ultim believ becom increasingli
import show stabil market share year progress
investor feel comfort innov invest spend
andrew lazar herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
